Seaview Investment Managers LLC Purchases 2,258 Shares of UnitedHealth Group Incorporated $UNH

by · The Cerbat Gem

Seaview Investment Managers LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 103.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,437 shares of the healthcare conglomerate’s stock after buying an additional 2,258 shares during the period. Seaview Investment Managers LLC’s holdings in UnitedHealth Group were worth $1,384,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Norges Bank purchased a new position in UnitedHealth Group in the second quarter worth $3,837,207,000. Nuveen LLC purchased a new position in shares of UnitedHealth Group in the 1st quarter worth about $3,846,764,000. Dodge & Cox increased its holdings in UnitedHealth Group by 117.7% during the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock worth $2,729,912,000 after buying an additional 4,730,192 shares during the last quarter. Wellington Management Group LLP raised its position in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. Finally, Amundi grew its position in shares of UnitedHealth Group by 33.8% during the 2nd quarter. Amundi now owns 6,191,871 shares of the healthcare conglomerate’s stock valued at $1,904,372,000 after acquiring an additional 1,565,245 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $330.61 on Friday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The stock has a market cap of $299.48 billion, a P/E ratio of 17.26, a P/E/G ratio of 2.18 and a beta of 0.43. The company has a 50 day moving average of $341.79 and a 200 day moving average of $315.93.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period in the previous year, the business earned $7.15 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. TD Cowen upped their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday, October 30th. The Goldman Sachs Group began coverage on UnitedHealth Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target on the stock. Barclays boosted their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. UBS Group increased their target price on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Finally, JPMorgan Chase & Co. upped their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $385.54.

Check Out Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading